IGC Pharma, Inc.
IGC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326205
No open-market purchases or sales by IGC Pharma, Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $1.41M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding IGC Pharma, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 26 | 26 | 0 |
| Shares | 3.05M | 2.95M | −104.0K (−3.4%) |
| Value | $1.31M | $937.3K | −$372.7K (−28.5%) |
New holders (4)
Institutions that held IGC Pharma, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 65,152 | $21.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 10,092 | $3.00K | 0.00% |
| The PNC Financial Services Group, Inc. | 400 | $128 | 0.00% |
| Northwestern Mutual Wealth Management Co | 2 | $1 | 0.00% |
Sold out (4)
Institutions that held IGC Pharma, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Vident Investment Advisory, LLC | 121,563 | $52.0K |
| Citadel Advisors LLC | 15,583 | $7.00K |
| FMR LLC | 300 | $0 |
| Steward Partners Investment Advisory, LLC | 300 | $0 |